Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
NCT06717412 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146
Last updated 2025-04-04
Summary
Evaluating the Optimal Effective Dose and Safety of Conbercept in Treating Retinopathy of Prematurity (ROP)
Conditions
- Retinopathy of Prematurity (ROP)
Interventions
- DRUG
-
Conbercept
Administered as an intravitreal injection
Sponsors & Collaborators
-
Wang Yusheng
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-29
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)
NCT00000156 ·Status: COMPLETED ·Phase: PHASE3
-
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
NCT06927414 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Exploratory Study of SAT-001 in Treatment of Pediatric Patient With Myopia
NCT05917041 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Low-Level Monochromatic Red-Light for High Myopia Control in Adults
NCT05947019 ·Status: UNKNOWN ·Phase: NA
-
Low Concentration Atropine in the Prevention of Myopia in Children.
NCT05939882 ·Status: UNKNOWN ·Phase: NA
-
Real-World Study of Myopia Prevention and Control in Children
NCT06849895 ·Status: NOT_YET_RECRUITING
-
Early-Onset Myopia Intervention Project
NCT07176949 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children
NCT06305663 ·Status: RECRUITING ·Phase: NA
-
A Randomized Clinical Trial on the Effectiveness of Novel Plano Spectacle Lenses on Myopia Prevention in Pre-myopic Children
NCT06860737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Novel Lenses for Myopia Progression Trial
NCT06563700 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Effectiveness of CARE1.02 Spectacle Lens in Myopia Control
NCT05818033 ·Status: COMPLETED ·Phase: NA
-
Red Light Intervention on Myopic Progression
NCT05203432 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
NCT04101721 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of RP and LCA by Primary RPE Transplantation
NCT03566147 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens
NCT05886348 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents
NCT05597163 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy Comparison of 2 Low-dose Atropine Eye Drops in Vietnamese Children Myopia Management
NCT05803863 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Enhancement of Emmetropization in Hyperopic Infants
NCT00574717 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
3D Designed Defocus Lenses on Myopia Control in Children and Adolescents
NCT07284147 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Efficacy and Safety of 1% Atropine "5+3" Regimen in Children and Adolescents Controlling Myopia
NCT05448989 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Posterior Scleral Reinforcement on Controlling Myopia in Adults With High Myopia
NCT03381079 ·Status: UNKNOWN ·Phase: PHASE2
-
Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression
NCT06717048 ·Status: RECRUITING ·Phase: NA
-
A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
NCT03201562 ·Status: COMPLETED ·Phase: PHASE2
-
Age and Refraction in Predicting Myopia Progression in COVID-19
NCT05305274 ·Status: COMPLETED
-
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
NCT06034327 ·Status: RECRUITING ·Phase: NA